BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23519608)

  • 1. Candidate agents for papillary thyroid cancer identified by gene expression analysis.
    Zhu W; Li C; Ai Z
    Pathol Oncol Res; 2013 Jul; 19(3):597-604. PubMed ID: 23519608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis.
    Qu T; Li YP; Li XH; Chen Y
    Mol Med Rep; 2016 Dec; 14(6):5041-5048. PubMed ID: 27779685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
    Zhao H; Li H
    Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
    Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
    World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
    Zhang H; Teng X; Liu Z; Zhang L; Liu Z
    J Exp Clin Cancer Res; 2015 Feb; 34(1):16. PubMed ID: 25887589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray technology to investigate genes associated with papillary thyroid carcinoma.
    Zhu X; Yao J; Tian W
    Mol Med Rep; 2015 May; 11(5):3729-33. PubMed ID: 25586635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Genes Associated with Papillary Thyroid Carcinoma (PTC) for Diagnosis by Integrated Analysis.
    Li WB; Zhou J; Xu L; Su XL; Liu Q; Pang H
    Horm Metab Res; 2016 Apr; 48(4):226-31. PubMed ID: 26756467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of
    Yang L; Zhang X; Zhang J; Liu Y; Ji T; Mou J; Fang X; Wang S; Chen J
    Future Oncol; 2022 Jan; 18(3):333-348. PubMed ID: 34756116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differential pathways in papillary thyroid carcinoma utilizing pathway co-expression analysis.
    Qiu WH; Chen GY; Cui L; Zhang TM; Wei F; Yang Y
    J BUON; 2016; 21(6):1501-1509. PubMed ID: 28039715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer.
    Liu C; Pan Y; Li Q; Zhang Y
    Int J Med Sci; 2021; 18(15):3478-3487. PubMed ID: 34522174
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction Biomarkers Associated with Lymph Node Metastasis and Prognosis were Identified in Papillary Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Gan S; Ye R; Ha Y; Xiong Y; Li R; Di X; Zou Z; Sun Y; Zhang Z
    Comb Chem High Throughput Screen; 2021; 24(9):1395-1409. PubMed ID: 33155892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and analysis of genes associated with papillary thyroid carcinoma by bioinformatics methods.
    Zhang S; Wang Q; Han Q; Han H; Lu P
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30872410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined use of miRNAs and mRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma.
    Zhao Y; Liu X; Zhong L; He M; Chen S; Wang T; Ma S
    Int J Mol Med; 2015 Oct; 36(4):1097-103. PubMed ID: 26252081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA sequencing identifies crucial genes in papillary thyroid carcinoma (PTC) progression.
    Qiu J; Zhang W; Xia Q; Liu F; Li L; Zhao S; Gao X; Zang C; Ge R; Sun Y
    Exp Mol Pathol; 2016 Feb; 100(1):151-9. PubMed ID: 26708423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAPILLARY THYROID CANCER IS CHARACTERIZED BY ALTERED EXPRESSION OF GENES INVOLVED IN THE SUMOYLATION PROCESS.
    Tuccilli C; Baldini E; Sorrenti S; Di Gioia C; Bosco D; Ascoli V; Mian C; Barollo S; Rendina R; Coccaro C; Pepe M; Catania A; Bononi M; Tartaglia F; De Antoni E; D'Armiento M; Ulisse S
    J Biol Regul Homeost Agents; 2015; 29(3):655-62. PubMed ID: 26403403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Special role of JUN in papillary thyroid carcinoma based on bioinformatics analysis.
    Chen W; Liu Q; Lv Y; Xu D; Chen W; Yu J
    World J Surg Oncol; 2017 Jul; 15(1):119. PubMed ID: 28673327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competing endogenous RNA regulatory network in papillary thyroid carcinoma.
    Chen S; Fan X; Gu H; Zhang L; Zhao W
    Mol Med Rep; 2018 Jul; 18(1):695-704. PubMed ID: 29767230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
    Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
    Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis.
    Xue G; Lin X; Wu JF; Pei D; Wang DM; Zhang J; Zhang WJ
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma.
    Sun M; Fang S; Li W; Li C; Wang L; Wang F; Wang Y
    Cancer Biomark; 2015; 15(1):33-40. PubMed ID: 25524940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.